Navigation Links
Genencor promotes biobased economy to address challenges of fast-growing world population
Date:10/5/2011

PALO ALTO, Calif. Oct. 5, 2011 Today at the first-annual California Industrial Biotechnology Conference, Genencor called for the collaboration of industry, science and policy stakeholders to help solve the challenges of a growing world population through accelerating a biobased economy. A biobased economy is driven by the use of renewable sources for energy, fuels and the production of chemicals and materials.

"The global population is expected to increase to 9 billion by 2050, and we are already experiencing challenges in meeting the needs for food, energy and protection," said Genencor CEO Tjerk de Ruiter. "Working together to power industrial biotechnology solutions and educate others about them can help boost the economy, reduce our dependence on fossil fuels, create a healthier environment and decrease water and energy consumption."

Genencor recommended four key components necessary for creating a biobased economy:

  • Cultivating a steady supply of renewable feedstock;

  • Developing infrastructure (from farm to factory);

  • Building sustainable biorefineries; and

  • Developing and securing responsive distribution channels.

De Ruiter said the best collaboration to help develop the foundation for a biobased economy needs to consist of: public and private partnerships; governmental policies and industry incentives; a regulatory framework that doesn't stifle entrepreneurial innovation; and public education. Genencor has been seeking new partnerships to address the needs of a growing population through its open innovative program called GNext, as well as making significant progress in developing cost-effective enzyme technologies that are helping to solve the world's sustainability issues.

For example, Genencor's newest enzyme technology, Accellerase TRIO, will help the United States reduce its dependence on a petroleum-based economy by allowing advanced biofuels producers to cost-effectively manufacture cellulosic ethanol from a range of renewable, nonfood feedstocks. Advanced biofuels have the potential to reduce greenhouse gas emissions up to 86 percent over gasoline.

Genencor's BioIsoprene platform is another biobased alternative for the rapidly growing automotive and transportation industries. A partnership between Genencor and The Goodyear Tire Company, BioIsoprene platform is an alternative to petroleum-derived isoprene, a key chemical in synthetic rubber. The technology also has a vast potential beyond tires, including becoming key ingredients in rubber products and adhesives.

"Indeed we are making progress. The challenge ahead of us is to work as a collective group to take discoveries from pilot projects to commercialization faster," De Ruiter said. "Working toward establishing a biobased economy will help us be better prepared to address society's biggest challenges."


'/>"/>

Contact: Chris Nguyen
chris.nguyen@danisco.com
650-276-9189
Environics
Source:Eurekalert

Related biology news :

1. Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes
2. Advancement in tissue engineering promotes oral wound healing
3. Prairie dog research promotes caring, conservation
4. Protein that promotes cancer cell growth identified
5. New Web site promotes interoperable newborn screening data
6. Newly identified growth factor promotes stem cell growth, regeneration
7. Rhodopsin phototrophy promotes bacterial survival
8. 2 dogs 2,000 miles trek promotes dog DNA for cancer research
9. Engineering textbook promotes social justice
10. CSHL team shows how loss of key protein promotes aggressive form of leukemia
11. Sewage overflow promotes spread of West Nile virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the addition of the "Global ... 2025" report to their offering. ... The Global Vehicle Anti-Theft System Market is ... next decade to reach approximately $14.21 billion by 2025. ... all the given segments on global as well as regional levels ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  Northwest Biotherapeutics (OTCQB: ... personalized immune therapies for solid tumor cancers, today ... million financing it announced last Friday, March 17, ... several institutional investors securities totaling 28,843,692 shares, comprised ... and 10,000,000 shares of Class C Warrants pre-funded ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... New Orleans, La. (PRWEB) , ... March 23, ... ... of real-time, industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” ... for APMT customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
Breaking Biology Technology: